ClinConnect ClinConnect Logo
Search / Trial NCT06404632

A Group Intervention for Promoting Health-related Habits (LEV-G)

Launched by REGION STOCKHOLM · May 5, 2024

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

ClinConnect Summary

The LEV-G clinical trial is studying a group program designed to help people improve their health-related habits, which can have a positive impact on both mental and physical well-being. Many individuals struggle with making healthy lifestyle choices, and this project aims to provide effective support for those who need it. The program is suitable for adults, including those with various disabilities, and seeks to make health care more accessible and effective for everyone.

To take part in the trial, participants should be adults aged between 18 and 80, with or without disabilities. However, those with severe intellectual disabilities, significant language barriers, or serious mental health issues may not be eligible. If you join this study, you can expect to participate in group sessions that focus on building healthier habits in a supportive environment. This trial is currently recruiting participants, and it's a great opportunity for individuals looking to make positive changes in their lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • both adults with and without disabilities recruited from different healthcare contexts.
  • Exclusion Criteria:
  • Intellectual disability of the degree where the participant is not able to follow the protocol in Lev.
  • Insufficient command of the Swedish language/ unable to understand the content.
  • Severe psychiatric comorbidity that makes participation difficult (e.g. severe depression, severe suicidality, severe anxiety, ongoing psychosis, manic episode), other circumstances that could make participation hard (e.g. homelessness).

About Region Stockholm

Region Stockholm is a leading healthcare authority committed to advancing medical research and improving patient care through innovative clinical trials. As a sponsor, Region Stockholm collaborates with hospitals, research institutions, and industry partners to facilitate the development of new therapies and treatment protocols. With a focus on quality, safety, and ethical standards, the organization aims to enhance health outcomes for the diverse population of Stockholm and beyond, leveraging cutting-edge research to translate scientific discoveries into effective healthcare solutions.

Locations

Stockholm, Stockholm, Sweden, Sweden

Stockholm, , Sweden

Patients applied

0 patients applied

Trial Officials

Douglas Sjöwall, PhD

Principal Investigator

Region Stockholm

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported